person · Reporting owner

De Crescenzo Neil E.

Disclosed activity across 2 companies

Tapewire entity: 44253
SEC CIK: 0001778464

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
CCC Intelligent Solutions Holdings Inc.CCC · Entity 4014	Director	May 21, 2026	May 26, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

CCC Intelligent Solutions Holdings Inc.

Report date May 21, 2026 · Filed May 26, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	241,839	Reported balance After 2026-05-21 transaction · row 1 1 source row Row 1 · 2026-05-21 · Exercise / conversion · Acquired 28,410 · Balance 241,839
Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	0	Reported balance After 2026-05-21 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2026-05-21 · Exercise / conversion · Disposed 28,410 · Balance 0 F1: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive, at the Issuer's discretion, (i) one share of Common Stock for each RSU, (ii) an amount of cash equal to the fair market value of such share of Common Stock on the date immediately preceding the date of settlement of the RSU, or (iii) a combination thereof. The RSUs vest on the earlier of May 22, 2026 and the date of the next annual meeting of the stockholders of the Issuer, generally subject to the Reporting Person's continued service to the Issuer through such vesting and settlement date.
Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	55,067	Reported balance After 2026-05-21 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2026-05-21 · Grant · Acquired 55,067 · Balance 55,067 F2: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive, at the Issuer's discretion, (i) one share of Common Stock for each RSU, (ii) an amount of cash equal to the fair market value of such share of Common Stock on the date immediately preceding the date of settlement of the RSU, or (iii) a combination thereof. The RSUs vest on the earlier of May 21, 2027 and the date of the next annual meeting of the stockholders of the Issuer, generally subject to the Reporting Person's continued service to the Issuer through such vesting and settlement date.

Filing footnotes · ownership attribution and instrument terms

F1: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive, at the Issuer's discretion, (i) one share of Common Stock for each RSU, (ii) an amount of cash equal to the fair market value of such share of Common Stock on the date immediately preceding the date of settlement of the RSU, or (iii) a combination thereof. The RSUs vest on the earlier of May 22, 2026 and the date of the next annual meeting of the stockholders of the Issuer, generally subject to the Reporting Person's continued service to the Issuer through such vesting and settlement date.

F2: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive, at the Issuer's discretion, (i) one share of Common Stock for each RSU, (ii) an amount of cash equal to the fair market value of such share of Common Stock on the date immediately preceding the date of settlement of the RSU, or (iii) a combination thereof. The RSUs vest on the earlier of May 21, 2027 and the date of the next annual meeting of the stockholders of the Issuer, generally subject to the Reporting Person's continued service to the Issuer through such vesting and settlement date.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Change Healthcare Inc.

Report date October 03, 2022 · Filed October 05, 2022

Section 16 reporting ended · disclosed 2022-10-05. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Ending reported balance After 2022-10-03 transaction · row 4 4 source rows · reconciled sequence Row 1 · 2022-10-03 · Disposition to issuer · Disposed 593,181 · Balance 743,947 F1: On October 3, 2022, UnitedHealth Group Incorporated ("UnitedHealth Group") acquired Change Healthcare Inc. (the "Issuer") pursuant to that certain Agreement and Plan of Merger dated as of January 5, 2021 (the "Merger Agreement") by and among the Issuer, UnitedHealth Group and Cambridge Merger Sub Inc., a wholly owned subsidiary of UnitedHealth Group ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of UnitedHealth Group. At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of common stock, par value $0.001 per share, of the Issuer (the "Common Stock") (other than certain excluded shares) automatically converted into the right to receive $25.75 per share in cash (the "Merger Consideration"), without interest and less any applicable holding tax. Row 2 · 2022-10-03 · Disposition to issuer · Disposed 743,947 · Balance 0 F2: Pursuant to the Merger Agreement, outstanding restricted stock units ("RSUs") of the Issuer were automatically converted into UnitedHealth Group RSUs calculated by taking the Merger Consideration and dividing it by the volume weighted average of the closing sale price per share of UnitedHealth Group common stock on each of the five full consecutive trading days ending on and including the third business day prior to the Merger closing date (the "Equity Award Exchange Ratio") and continue to be subject to the same terms and conditions (including vesting and settlement terms) as were applicable to the Issuer RSUs. Row 3 · 2022-10-03 · Grant · Acquired 220,264 · Balance 220,264 F3: Reflects performance based restricted stock units ("PSUs") granted on October 29, 2020 which were originally scheduled to vest based on the achievement of certain performance criteria. Pursuant to the Merger Agreement, PSUs of the Issuer were automatically converted into time-vesting UnitedHealth Group RSUs, with the number of shares of UnitedHealth Group common stock subject to the UnitedHealth Group RSUs equal to (i) the number of shares of Common Stock underlying the Issuer PSUs based on target performance multiplied by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group RSUs will continue to be subject to the same terms and conditions as were applicable to the Issuer PSUs, and will vest on June 17, 2023. Row 4 · 2022-10-03 · Disposition to issuer · Disposed 220,264 · Balance 0 F3: Reflects performance based restricted stock units ("PSUs") granted on October 29, 2020 which were originally scheduled to vest based on the achievement of certain performance criteria. Pursuant to the Merger Agreement, PSUs of the Issuer were automatically converted into time-vesting UnitedHealth Group RSUs, with the number of shares of UnitedHealth Group common stock subject to the UnitedHealth Group RSUs equal to (i) the number of shares of Common Stock underlying the Issuer PSUs based on target performance multiplied by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group RSUs will continue to be subject to the same terms and conditions as were applicable to the Issuer PSUs, and will vest on June 17, 2023.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.99 · Expires 2027-08-08	Direct	Reported balance After 2022-10-03 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2022-10-03 · Disposition to issuer · Disposed 632,000 · Balance 0 F4: In connection with the Merger, stock option awards of the Issuer were automatically converted into an option to purchase a number of shares of common stock of UnitedHealth Group equal to the product of (i) the number of shares of Common Stock subject to the Issuer Stock option multiplied by (ii) the Equity Award Exchange Ratio, at an exercise price per share equal to (i) the exercise price of the Issuer stock option divided by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group options will continue to be subject to the same terms and conditions as were applicable to the existing Issuer stock option. F5: These options vest in three equal annual installments commencing on June 30, 2022.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.99 · Expires 2028-05-25	Direct	Reported balance After 2022-10-03 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2022-10-03 · Disposition to issuer · Disposed 94,800 · Balance 0 F4: In connection with the Merger, stock option awards of the Issuer were automatically converted into an option to purchase a number of shares of common stock of UnitedHealth Group equal to the product of (i) the number of shares of Common Stock subject to the Issuer Stock option multiplied by (ii) the Equity Award Exchange Ratio, at an exercise price per share equal to (i) the exercise price of the Issuer stock option divided by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group options will continue to be subject to the same terms and conditions as were applicable to the existing Issuer stock option. F6: These options vest in three equal annual installments commencing on June 30, 2022.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.07 · Expires 2023-09-30	Direct	Reported balance After 2022-10-03 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2022-10-03 · Disposition to issuer · Disposed 792,784 · Balance 0 F4: In connection with the Merger, stock option awards of the Issuer were automatically converted into an option to purchase a number of shares of common stock of UnitedHealth Group equal to the product of (i) the number of shares of Common Stock subject to the Issuer Stock option multiplied by (ii) the Equity Award Exchange Ratio, at an exercise price per share equal to (i) the exercise price of the Issuer stock option divided by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group options will continue to be subject to the same terms and conditions as were applicable to the existing Issuer stock option. F7: These options are fully vested.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $19.58 · Expires 2023-09-30	Direct	Reported balance After 2022-10-03 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2022-10-03 · Disposition to issuer · Disposed 316,000 · Balance 0 F4: In connection with the Merger, stock option awards of the Issuer were automatically converted into an option to purchase a number of shares of common stock of UnitedHealth Group equal to the product of (i) the number of shares of Common Stock subject to the Issuer Stock option multiplied by (ii) the Equity Award Exchange Ratio, at an exercise price per share equal to (i) the exercise price of the Issuer stock option divided by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group options will continue to be subject to the same terms and conditions as were applicable to the existing Issuer stock option. F7: These options are fully vested.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.99 · Expires 2027-08-08	Direct	Reported balance After 2022-10-03 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2022-10-03 · Disposition to issuer · Disposed 632,000 · Balance 0 F4: In connection with the Merger, stock option awards of the Issuer were automatically converted into an option to purchase a number of shares of common stock of UnitedHealth Group equal to the product of (i) the number of shares of Common Stock subject to the Issuer Stock option multiplied by (ii) the Equity Award Exchange Ratio, at an exercise price per share equal to (i) the exercise price of the Issuer stock option divided by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group options will continue to be subject to the same terms and conditions as were applicable to the existing Issuer stock option. F7: These options are fully vested.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.99 · Expires 2028-05-25	Direct	Reported balance After 2022-10-03 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2022-10-03 · Disposition to issuer · Disposed 94,800 · Balance 0 F4: In connection with the Merger, stock option awards of the Issuer were automatically converted into an option to purchase a number of shares of common stock of UnitedHealth Group equal to the product of (i) the number of shares of Common Stock subject to the Issuer Stock option multiplied by (ii) the Equity Award Exchange Ratio, at an exercise price per share equal to (i) the exercise price of the Issuer stock option divided by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group options will continue to be subject to the same terms and conditions as were applicable to the existing Issuer stock option. F7: These options are fully vested.
Stock Appreciation rightSEC Table II · derivative / convertible security · Conversion / exercise price $0.38 · Expires 2023-09-30	Direct	Reported balance After 2022-10-03 transaction · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · 2022-10-03 · Disposition to issuer · Disposed 314,595 · Balance 0 F8: These stock appreciation rights ("SARs") are fully vested. Pursuant to the Merger Agreement, the SARs were automatically converted into SARs of UnitedHealth Group, denominated in a number of shares of common stock of UnitedHealth Group equal to the product of the number of shares of Common Stock subject to the Issuer SARs multiplied by the Equity Award Exchange Ratio, at an exercise price per share equal to the strike price per share applicable to such SAR divided by the Equity Award Exchange Ratio. The UnitedHealth Group SARs will continue to be subject to the same terms and conditions as were applicable to the Issuer SARs. F9: Reflects a correction to the expiration date of the SARs reported in the Reporting Person's previously filed Form 4 reporting such SARs.

Filing footnotes · ownership attribution and instrument terms

F1: On October 3, 2022, UnitedHealth Group Incorporated ("UnitedHealth Group") acquired Change Healthcare Inc. (the "Issuer") pursuant to that certain Agreement and Plan of Merger dated as of January 5, 2021 (the "Merger Agreement") by and among the Issuer, UnitedHealth Group and Cambridge Merger Sub Inc., a wholly owned subsidiary of UnitedHealth Group ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of UnitedHealth Group. At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of common stock, par value $0.001 per share, of the Issuer (the "Common Stock") (other than certain excluded shares) automatically converted into the right to receive $25.75 per share in cash (the "Merger Consideration"), without interest and less any applicable holding tax.

F2: Pursuant to the Merger Agreement, outstanding restricted stock units ("RSUs") of the Issuer were automatically converted into UnitedHealth Group RSUs calculated by taking the Merger Consideration and dividing it by the volume weighted average of the closing sale price per share of UnitedHealth Group common stock on each of the five full consecutive trading days ending on and including the third business day prior to the Merger closing date (the "Equity Award Exchange Ratio") and continue to be subject to the same terms and conditions (including vesting and settlement terms) as were applicable to the Issuer RSUs.

F3: Reflects performance based restricted stock units ("PSUs") granted on October 29, 2020 which were originally scheduled to vest based on the achievement of certain performance criteria. Pursuant to the Merger Agreement, PSUs of the Issuer were automatically converted into time-vesting UnitedHealth Group RSUs, with the number of shares of UnitedHealth Group common stock subject to the UnitedHealth Group RSUs equal to (i) the number of shares of Common Stock underlying the Issuer PSUs based on target performance multiplied by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group RSUs will continue to be subject to the same terms and conditions as were applicable to the Issuer PSUs, and will vest on June 17, 2023.

F4: In connection with the Merger, stock option awards of the Issuer were automatically converted into an option to purchase a number of shares of common stock of UnitedHealth Group equal to the product of (i) the number of shares of Common Stock subject to the Issuer Stock option multiplied by (ii) the Equity Award Exchange Ratio, at an exercise price per share equal to (i) the exercise price of the Issuer stock option divided by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group options will continue to be subject to the same terms and conditions as were applicable to the existing Issuer stock option.

F5: These options vest in three equal annual installments commencing on June 30, 2022.

F6: These options vest in three equal annual installments commencing on June 30, 2022.

F7: These options are fully vested.

F8: These stock appreciation rights ("SARs") are fully vested. Pursuant to the Merger Agreement, the SARs were automatically converted into SARs of UnitedHealth Group, denominated in a number of shares of common stock of UnitedHealth Group equal to the product of the number of shares of Common Stock subject to the Issuer SARs multiplied by the Equity Award Exchange Ratio, at an exercise price per share equal to the strike price per share applicable to such SAR divided by the Equity Award Exchange Ratio. The UnitedHealth Group SARs will continue to be subject to the same terms and conditions as were applicable to the Issuer SARs.

F9: Reflects a correction to the expiration date of the SARs reported in the Reporting Person's previously filed Form 4 reporting such SARs.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
May 21, 2026 Filed May 26, 2026 12:23 UTC	CCC Intelligent Solutions Holdings Inc. CCC · Entity 4014	GrantRestricted Stock Unit · Derivative	55,067	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001818201-26-000034 · form4.xml · derivative · entry 3 De Crescenzo Neil E. · CIK 0001778464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,067 Underlying: Common Stock · 55,067 shares Expires not disclosed F2 · security: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive, at the Issuer's discretion, (i) one share of Common Stock for each RSU, (ii) an amount of cash equal to the fair market value of such share of Common Stock on the date immediately preceding the date of settlement of the RSU, or (iii) a combination thereof. The RSUs vest on the earlier of May 21, 2027 and the date of the next annual meeting of the stockholders of the Issuer, generally subject to the Reporting Person's continued service to the Issuer through such vesting and settlement date. F2 · derivative.exercise_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive, at the Issuer's discretion, (i) one share of Common Stock for each RSU, (ii) an amount of cash equal to the fair market value of such share of Common Stock on the date immediately preceding the date of settlement of the RSU, or (iii) a combination thereof. The RSUs vest on the earlier of May 21, 2027 and the date of the next annual meeting of the stockholders of the Issuer, generally subject to the Reporting Person's continued service to the Issuer through such vesting and settlement date. F2 · derivative.expiration_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive, at the Issuer's discretion, (i) one share of Common Stock for each RSU, (ii) an amount of cash equal to the fair market value of such share of Common Stock on the date immediately preceding the date of settlement of the RSU, or (iii) a combination thereof. The RSUs vest on the earlier of May 21, 2027 and the date of the next annual meeting of the stockholders of the Issuer, generally subject to the Reporting Person's continued service to the Issuer through such vesting and settlement date. Read SEC document
May 21, 2026 Filed May 26, 2026 12:23 UTC	CCC Intelligent Solutions Holdings Inc. CCC · Entity 4014	Exercise / conversionRestricted Stock Unit · Derivative	28,410	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001818201-26-000034 · form4.xml · derivative · entry 2 De Crescenzo Neil E. · CIK 0001778464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28,410 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive, at the Issuer's discretion, (i) one share of Common Stock for each RSU, (ii) an amount of cash equal to the fair market value of such share of Common Stock on the date immediately preceding the date of settlement of the RSU, or (iii) a combination thereof. The RSUs vest on the earlier of May 22, 2026 and the date of the next annual meeting of the stockholders of the Issuer, generally subject to the Reporting Person's continued service to the Issuer through such vesting and settlement date. F1 · derivative.exercise_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive, at the Issuer's discretion, (i) one share of Common Stock for each RSU, (ii) an amount of cash equal to the fair market value of such share of Common Stock on the date immediately preceding the date of settlement of the RSU, or (iii) a combination thereof. The RSUs vest on the earlier of May 22, 2026 and the date of the next annual meeting of the stockholders of the Issuer, generally subject to the Reporting Person's continued service to the Issuer through such vesting and settlement date. F1 · derivative.expiration_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive, at the Issuer's discretion, (i) one share of Common Stock for each RSU, (ii) an amount of cash equal to the fair market value of such share of Common Stock on the date immediately preceding the date of settlement of the RSU, or (iii) a combination thereof. The RSUs vest on the earlier of May 22, 2026 and the date of the next annual meeting of the stockholders of the Issuer, generally subject to the Reporting Person's continued service to the Issuer through such vesting and settlement date. Read SEC document
May 21, 2026 Filed May 26, 2026 12:23 UTC	CCC Intelligent Solutions Holdings Inc. CCC · Entity 4014	Exercise / conversionCommon Stock	28,410	$0.00	$0.00	Disclosure SEC source: 0001818201-26-000034 · form4.xml · nonDerivative · entry 1 De Crescenzo Neil E. · CIK 0001778464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 241,839 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 23, 2025 Filed May 27, 2025 21:54 UTC	CCC Intelligent Solutions Holdings Inc. CCCS · Entity 4014	PurchaseCommon Stock	100,000	$8.54	$853,560.00	Disclosure SEC source: 0001127602-25-015725 · form4.xml · nonDerivative · entry 2 De Crescenzo Neil E. · CIK 0001778464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 213,429 F1 · price: The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $8.4500 to $8.6300. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range provided. Read SEC document
May 22, 2025 Filed May 27, 2025 21:54 UTC	CCC Intelligent Solutions Holdings Inc. CCCS · Entity 4014	Exercise / conversionRestricted Stock Unit · Derivative	13,429	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001127602-25-015725 · form4.xml · derivative · entry 4 De Crescenzo Neil E. · CIK 0001778464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,429 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive, at the Issuer's discretion, (i) one share of Common Stock for each RSU, (ii) an amount of cash equal to the fair market value of such share of Common Stock on the date immediately preceding the date of settlement of the RSU, or (iii) a combination thereof. The RSUs vest on the earlier of November 6, 2025 and the date of the next annual meeting of the stockholders of the Issuer, generally subject to the Reporting Person's continued service to the Issuer through such vesting and settlement date. F3 · derivative.exercise_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive, at the Issuer's discretion, (i) one share of Common Stock for each RSU, (ii) an amount of cash equal to the fair market value of such share of Common Stock on the date immediately preceding the date of settlement of the RSU, or (iii) a combination thereof. The RSUs vest on the earlier of November 6, 2025 and the date of the next annual meeting of the stockholders of the Issuer, generally subject to the Reporting Person's continued service to the Issuer through such vesting and settlement date. F3 · derivative.expiration_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive, at the Issuer's discretion, (i) one share of Common Stock for each RSU, (ii) an amount of cash equal to the fair market value of such share of Common Stock on the date immediately preceding the date of settlement of the RSU, or (iii) a combination thereof. The RSUs vest on the earlier of November 6, 2025 and the date of the next annual meeting of the stockholders of the Issuer, generally subject to the Reporting Person's continued service to the Issuer through such vesting and settlement date. Read SEC document
May 22, 2025 Filed May 27, 2025 21:54 UTC	CCC Intelligent Solutions Holdings Inc. CCCS · Entity 4014	GrantRestricted Stock Unit · Derivative	28,410	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001127602-25-015725 · form4.xml · derivative · entry 3 De Crescenzo Neil E. · CIK 0001778464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,410 Underlying: Common Stock · 28,410 shares Expires not disclosed F2 · security: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive, at the Issuer's discretion, (i) one share of Common Stock for each RSU, (ii) an amount of cash equal to the fair market value of such share of Common Stock on the date immediately preceding the date of settlement of the RSU, or (iii) a combination thereof. The RSUs vest on the earlier of May 22, 2026 and the date of the next annual meeting of the stockholders of the Issuer, generally subject to the Reporting Person's continued service to the Issuer through such vesting and settlement date. F2 · derivative.exercise_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive, at the Issuer's discretion, (i) one share of Common Stock for each RSU, (ii) an amount of cash equal to the fair market value of such share of Common Stock on the date immediately preceding the date of settlement of the RSU, or (iii) a combination thereof. The RSUs vest on the earlier of May 22, 2026 and the date of the next annual meeting of the stockholders of the Issuer, generally subject to the Reporting Person's continued service to the Issuer through such vesting and settlement date. F2 · derivative.expiration_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive, at the Issuer's discretion, (i) one share of Common Stock for each RSU, (ii) an amount of cash equal to the fair market value of such share of Common Stock on the date immediately preceding the date of settlement of the RSU, or (iii) a combination thereof. The RSUs vest on the earlier of May 22, 2026 and the date of the next annual meeting of the stockholders of the Issuer, generally subject to the Reporting Person's continued service to the Issuer through such vesting and settlement date. Read SEC document
May 22, 2025 Filed May 27, 2025 21:54 UTC	CCC Intelligent Solutions Holdings Inc. CCCS · Entity 4014	Exercise / conversionCommon Stock	13,429	$0.00	$0.00	Disclosure SEC source: 0001127602-25-015725 · form4.xml · nonDerivative · entry 1 De Crescenzo Neil E. · CIK 0001778464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,429 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
December 20, 2024 Filed Dec 23, 2024 22:27 UTC	CCC Intelligent Solutions Holdings Inc. CCCS · Entity 4014	PurchaseCommon Stock	100,000	$12.16	$1,216,240.00	Disclosure SEC source: 0001127602-24-029986 · form4.xml · nonDerivative · entry 1 De Crescenzo Neil E. · CIK 0001778464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $12.0200 to $12.2800. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range provided. Read SEC document
November 06, 2024 Filed Nov 8, 2024 23:36 UTC	CCC Intelligent Solutions Holdings Inc. CCCS · Entity 4014	GrantRestricted Stock Unit · Derivative	13,429	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001127602-24-026878 · form4.xml · derivative · entry 1 De Crescenzo Neil E. · CIK 0001778464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,429 Underlying: Common Stock · 13,429 shares Expires not disclosed F1 · security: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive, at the Issuer's discretion, (i) one share of Common Stock for each RSU, (ii) an amount of cash equal to the fair market value of such share of Common Stock on the date immediately preceding the date of settlement of the RSU, or (iii) a combination thereof. The RSUs vest on the earlier of November 6, 2025 and the date of the next annual meeting of the stockholders of the Issuer, generally subject to the Reporting Person's continued service to the Issuer through such vesting and settlement date. F1 · derivative.exercise_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive, at the Issuer's discretion, (i) one share of Common Stock for each RSU, (ii) an amount of cash equal to the fair market value of such share of Common Stock on the date immediately preceding the date of settlement of the RSU, or (iii) a combination thereof. The RSUs vest on the earlier of November 6, 2025 and the date of the next annual meeting of the stockholders of the Issuer, generally subject to the Reporting Person's continued service to the Issuer through such vesting and settlement date. F1 · derivative.expiration_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive, at the Issuer's discretion, (i) one share of Common Stock for each RSU, (ii) an amount of cash equal to the fair market value of such share of Common Stock on the date immediately preceding the date of settlement of the RSU, or (iii) a combination thereof. The RSUs vest on the earlier of November 6, 2025 and the date of the next annual meeting of the stockholders of the Issuer, generally subject to the Reporting Person's continued service to the Issuer through such vesting and settlement date. Read SEC document
October 03, 2022 Filed Oct 5, 2022 16:31 UTC	Change Healthcare Inc. CHNG · Entity 15437	Disposition to issuerStock Appreciation right · Derivative	314,595	Not disclosed Strike: $0.38	Not disclosed	Disclosure SEC source: 0000899243-22-033012 · doc4.xml · derivative · entry 11 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 314,595 shares Expires 2023-09-30 F8 · price: These stock appreciation rights ("SARs") are fully vested. Pursuant to the Merger Agreement, the SARs were automatically converted into SARs of UnitedHealth Group, denominated in a number of shares of common stock of UnitedHealth Group equal to the product of the number of shares of Common Stock subject to the Issuer SARs multiplied by the Equity Award Exchange Ratio, at an exercise price per share equal to the strike price per share applicable to such SAR divided by the Equity Award Exchange Ratio. The UnitedHealth Group SARs will continue to be subject to the same terms and conditions as were applicable to the Issuer SARs. F8 · derivative.exercise_date: These stock appreciation rights ("SARs") are fully vested. Pursuant to the Merger Agreement, the SARs were automatically converted into SARs of UnitedHealth Group, denominated in a number of shares of common stock of UnitedHealth Group equal to the product of the number of shares of Common Stock subject to the Issuer SARs multiplied by the Equity Award Exchange Ratio, at an exercise price per share equal to the strike price per share applicable to such SAR divided by the Equity Award Exchange Ratio. The UnitedHealth Group SARs will continue to be subject to the same terms and conditions as were applicable to the Issuer SARs. F9 · derivative.expiration_date: Reflects a correction to the expiration date of the SARs reported in the Reporting Person's previously filed Form 4 reporting such SARs. Read SEC document
October 03, 2022 Filed Oct 5, 2022 16:31 UTC	Change Healthcare Inc. CHNG · Entity 15437	Disposition to issuerStock Option (right to buy) · Derivative	94,800	Not disclosed Strike: $18.99	Not disclosed	Disclosure SEC source: 0000899243-22-033012 · doc4.xml · derivative · entry 10 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 94,800 shares Expires 2028-05-25 F4 · price: In connection with the Merger, stock option awards of the Issuer were automatically converted into an option to purchase a number of shares of common stock of UnitedHealth Group equal to the product of (i) the number of shares of Common Stock subject to the Issuer Stock option multiplied by (ii) the Equity Award Exchange Ratio, at an exercise price per share equal to (i) the exercise price of the Issuer stock option divided by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group options will continue to be subject to the same terms and conditions as were applicable to the existing Issuer stock option. F7 · derivative.exercise_date: These options are fully vested. Read SEC document
October 03, 2022 Filed Oct 5, 2022 16:31 UTC	Change Healthcare Inc. CHNG · Entity 15437	Disposition to issuerStock Option (right to buy) · Derivative	632,000	Not disclosed Strike: $18.99	Not disclosed	Disclosure SEC source: 0000899243-22-033012 · doc4.xml · derivative · entry 9 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 632,000 shares Expires 2027-08-08 F4 · price: In connection with the Merger, stock option awards of the Issuer were automatically converted into an option to purchase a number of shares of common stock of UnitedHealth Group equal to the product of (i) the number of shares of Common Stock subject to the Issuer Stock option multiplied by (ii) the Equity Award Exchange Ratio, at an exercise price per share equal to (i) the exercise price of the Issuer stock option divided by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group options will continue to be subject to the same terms and conditions as were applicable to the existing Issuer stock option. F7 · derivative.exercise_date: These options are fully vested. Read SEC document
October 03, 2022 Filed Oct 5, 2022 16:31 UTC	Change Healthcare Inc. CHNG · Entity 15437	Disposition to issuerStock Option (right to buy) · Derivative	316,000	Not disclosed Strike: $19.58	Not disclosed	Disclosure SEC source: 0000899243-22-033012 · doc4.xml · derivative · entry 8 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 316,000 shares Expires 2023-09-30 F4 · price: In connection with the Merger, stock option awards of the Issuer were automatically converted into an option to purchase a number of shares of common stock of UnitedHealth Group equal to the product of (i) the number of shares of Common Stock subject to the Issuer Stock option multiplied by (ii) the Equity Award Exchange Ratio, at an exercise price per share equal to (i) the exercise price of the Issuer stock option divided by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group options will continue to be subject to the same terms and conditions as were applicable to the existing Issuer stock option. F7 · derivative.exercise_date: These options are fully vested. Read SEC document
October 03, 2022 Filed Oct 5, 2022 16:31 UTC	Change Healthcare Inc. CHNG · Entity 15437	Disposition to issuerStock Option (right to buy) · Derivative	792,784	Not disclosed Strike: $8.07	Not disclosed	Disclosure SEC source: 0000899243-22-033012 · doc4.xml · derivative · entry 7 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 792,784 shares Expires 2023-09-30 F4 · price: In connection with the Merger, stock option awards of the Issuer were automatically converted into an option to purchase a number of shares of common stock of UnitedHealth Group equal to the product of (i) the number of shares of Common Stock subject to the Issuer Stock option multiplied by (ii) the Equity Award Exchange Ratio, at an exercise price per share equal to (i) the exercise price of the Issuer stock option divided by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group options will continue to be subject to the same terms and conditions as were applicable to the existing Issuer stock option. F7 · derivative.exercise_date: These options are fully vested. Read SEC document
October 03, 2022 Filed Oct 5, 2022 16:31 UTC	Change Healthcare Inc. CHNG · Entity 15437	Disposition to issuerStock Option (right to buy) · Derivative	94,800	Not disclosed Strike: $18.99	Not disclosed	Disclosure SEC source: 0000899243-22-033012 · doc4.xml · derivative · entry 6 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 94,800 shares Expires 2028-05-25 F4 · price: In connection with the Merger, stock option awards of the Issuer were automatically converted into an option to purchase a number of shares of common stock of UnitedHealth Group equal to the product of (i) the number of shares of Common Stock subject to the Issuer Stock option multiplied by (ii) the Equity Award Exchange Ratio, at an exercise price per share equal to (i) the exercise price of the Issuer stock option divided by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group options will continue to be subject to the same terms and conditions as were applicable to the existing Issuer stock option. F6 · derivative.exercise_date: These options vest in three equal annual installments commencing on June 30, 2022. Read SEC document
October 03, 2022 Filed Oct 5, 2022 16:31 UTC	Change Healthcare Inc. CHNG · Entity 15437	Disposition to issuerStock Option (right to buy) · Derivative	632,000	Not disclosed Strike: $18.99	Not disclosed	Disclosure SEC source: 0000899243-22-033012 · doc4.xml · derivative · entry 5 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 632,000 shares Expires 2027-08-08 F4 · price: In connection with the Merger, stock option awards of the Issuer were automatically converted into an option to purchase a number of shares of common stock of UnitedHealth Group equal to the product of (i) the number of shares of Common Stock subject to the Issuer Stock option multiplied by (ii) the Equity Award Exchange Ratio, at an exercise price per share equal to (i) the exercise price of the Issuer stock option divided by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group options will continue to be subject to the same terms and conditions as were applicable to the existing Issuer stock option. F5 · derivative.exercise_date: These options vest in three equal annual installments commencing on June 30, 2022. Read SEC document
October 03, 2022 Filed Oct 5, 2022 16:31 UTC	Change Healthcare Inc. CHNG · Entity 15437	Disposition to issuerCommon Stock	220,264	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-22-033012 · doc4.xml · nonDerivative · entry 4 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F3 · shares: Reflects performance based restricted stock units ("PSUs") granted on October 29, 2020 which were originally scheduled to vest based on the achievement of certain performance criteria. Pursuant to the Merger Agreement, PSUs of the Issuer were automatically converted into time-vesting UnitedHealth Group RSUs, with the number of shares of UnitedHealth Group common stock subject to the UnitedHealth Group RSUs equal to (i) the number of shares of Common Stock underlying the Issuer PSUs based on target performance multiplied by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group RSUs will continue to be subject to the same terms and conditions as were applicable to the Issuer PSUs, and will vest on June 17, 2023. F3 · price: Reflects performance based restricted stock units ("PSUs") granted on October 29, 2020 which were originally scheduled to vest based on the achievement of certain performance criteria. Pursuant to the Merger Agreement, PSUs of the Issuer were automatically converted into time-vesting UnitedHealth Group RSUs, with the number of shares of UnitedHealth Group common stock subject to the UnitedHealth Group RSUs equal to (i) the number of shares of Common Stock underlying the Issuer PSUs based on target performance multiplied by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group RSUs will continue to be subject to the same terms and conditions as were applicable to the Issuer PSUs, and will vest on June 17, 2023. Read SEC document
October 03, 2022 Filed Oct 5, 2022 16:31 UTC	Change Healthcare Inc. CHNG · Entity 15437	GrantCommon Stock	220,264	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-22-033012 · doc4.xml · nonDerivative · entry 3 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,264 F3 · shares: Reflects performance based restricted stock units ("PSUs") granted on October 29, 2020 which were originally scheduled to vest based on the achievement of certain performance criteria. Pursuant to the Merger Agreement, PSUs of the Issuer were automatically converted into time-vesting UnitedHealth Group RSUs, with the number of shares of UnitedHealth Group common stock subject to the UnitedHealth Group RSUs equal to (i) the number of shares of Common Stock underlying the Issuer PSUs based on target performance multiplied by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group RSUs will continue to be subject to the same terms and conditions as were applicable to the Issuer PSUs, and will vest on June 17, 2023. F3 · price: Reflects performance based restricted stock units ("PSUs") granted on October 29, 2020 which were originally scheduled to vest based on the achievement of certain performance criteria. Pursuant to the Merger Agreement, PSUs of the Issuer were automatically converted into time-vesting UnitedHealth Group RSUs, with the number of shares of UnitedHealth Group common stock subject to the UnitedHealth Group RSUs equal to (i) the number of shares of Common Stock underlying the Issuer PSUs based on target performance multiplied by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group RSUs will continue to be subject to the same terms and conditions as were applicable to the Issuer PSUs, and will vest on June 17, 2023. Read SEC document
October 03, 2022 Filed Oct 5, 2022 16:31 UTC	Change Healthcare Inc. CHNG · Entity 15437	Disposition to issuerCommon Stock	743,947	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-22-033012 · doc4.xml · nonDerivative · entry 2 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · shares: Pursuant to the Merger Agreement, outstanding restricted stock units ("RSUs") of the Issuer were automatically converted into UnitedHealth Group RSUs calculated by taking the Merger Consideration and dividing it by the volume weighted average of the closing sale price per share of UnitedHealth Group common stock on each of the five full consecutive trading days ending on and including the third business day prior to the Merger closing date (the "Equity Award Exchange Ratio") and continue to be subject to the same terms and conditions (including vesting and settlement terms) as were applicable to the Issuer RSUs. F2 · price: Pursuant to the Merger Agreement, outstanding restricted stock units ("RSUs") of the Issuer were automatically converted into UnitedHealth Group RSUs calculated by taking the Merger Consideration and dividing it by the volume weighted average of the closing sale price per share of UnitedHealth Group common stock on each of the five full consecutive trading days ending on and including the third business day prior to the Merger closing date (the "Equity Award Exchange Ratio") and continue to be subject to the same terms and conditions (including vesting and settlement terms) as were applicable to the Issuer RSUs. Read SEC document
October 03, 2022 Filed Oct 5, 2022 16:31 UTC	Change Healthcare Inc. CHNG · Entity 15437	Disposition to issuerCommon Stock	593,181	$25.75	$15,274,410.75	Disclosure SEC source: 0000899243-22-033012 · doc4.xml · nonDerivative · entry 1 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 743,947 F1 · price: On October 3, 2022, UnitedHealth Group Incorporated ("UnitedHealth Group") acquired Change Healthcare Inc. (the "Issuer") pursuant to that certain Agreement and Plan of Merger dated as of January 5, 2021 (the "Merger Agreement") by and among the Issuer, UnitedHealth Group and Cambridge Merger Sub Inc., a wholly owned subsidiary of UnitedHealth Group ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of UnitedHealth Group. At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of common stock, par value $0.001 per share, of the Issuer (the "Common Stock") (other than certain excluded shares) automatically converted into the right to receive $25.75 per share in cash (the "Merger Consideration"), without interest and less any applicable holding tax. Read SEC document
July 15, 2022 Filed Jul 19, 2022 17:03 UTC	Change Healthcare Inc. CHNG · Entity 15437	Tax withholdingCommon Stock	12,356	$23.52	$290,613.12	Disclosure SEC source: 0001062993-22-016517 · form4.xml · nonDerivative · entry 1 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,337,128 F1 · kind: Represents shares surrendered to satisfy tax withholding obligations in connection with the vesting of restricted stock units originally granted on April 15, 2022. Read SEC document
July 02, 2022 Filed Jul 6, 2022 16:42 UTC	Change Healthcare Inc. CHNG · Entity 15437	Tax withholdingCommon Stock	74,634	$23.72	$1,770,318.48	Disclosure SEC source: 0001062993-22-016077 · form4.xml · nonDerivative · entry 1 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,349,484 F1 · kind: Represents shares surrendered to satisfy tax withholding obligations in connection with the vesting of performance based restricted stock units originally granted on August 20, 2019. Read SEC document
June 01, 2022 Filed Jun 3, 2022 16:30 UTC	Change Healthcare Inc. CHNG · Entity 15437	GrantCommon Stock	199,099	$0.00	$0.00	Disclosure SEC source: 0000899243-22-020962 · doc4.xml · nonDerivative · entry 1 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,424,118 F1 · shares: Reflects an August 20, 2019 grant of performance based restricted stock units for which, on June 1, 2022, the Company certified performance. Such restricted stock units shall vest on July 2, 2022. Read SEC document
April 21, 2022 Filed Apr 25, 2022 17:03 UTC	Change Healthcare Inc. CHNG · Entity 15437	GrantStock Option (Right to Buy) · Derivative	94,800	$0.00 Strike: $18.99	$0.00	Disclosure SEC source: 0001062993-22-010728 · form4.xml · derivative · entry 2 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,800 Underlying: Common Stock · 94,800 shares Expires 2028-05-25 F2 · derivative.exercise_date: Reflects a May 25, 2018 option grant which was previously not required to be reported as a derivative security. On April 21, 2022, the Company approved an additional service-based vesting opportunity for the options. Options to vest in three equal annual installments, subject to the Reporting Person's continued employment through the applicable vesting date, commencing upon the earlier to occur of: (a) the Exit Event or (b) June 30, 2022. Read SEC document
April 21, 2022 Filed Apr 25, 2022 17:03 UTC	Change Healthcare Inc. CHNG · Entity 15437	GrantStock Option (Right to Buy) · Derivative	632,000	$0.00 Strike: $18.99	$0.00	Disclosure SEC source: 0001062993-22-010728 · form4.xml · derivative · entry 1 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 632,000 Underlying: Common Stock · 632,000 shares Expires 2027-08-08 F1 · derivative.exercise_date: Reflects an August 7, 2017 option grant (the "2017 Option Grant") which was previously not required to be reported as a derivative security. On April 21, 2022, the Company approved an additional service-based vesting opportunity for the options. Options to vest in three equal annual installments, subject to the Reporting Person's continued employment through the applicable vesting date, commencing upon the earlier to occur of: (a) affiliates of Blackstone Inc. selling more than 25% of the equity interests of the Company (the "Exit Event") or (b) June 30, 2022. Any options outstanding under 2017 Option Grant will fully vest and become exercisable upon an Exit Event in which the equity interests are sold at a weighted average price in excess of $33.23 per share. Read SEC document
April 15, 2022 Filed Apr 19, 2022 17:03 UTC	Change Healthcare Inc. CHNG · Entity 15437	GrantCommon Stock	376,773	$0.00	$0.00	Disclosure SEC source: 0001062993-22-010439 · form4.xml · nonDerivative · entry 1 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,225,019 F1 · shares: Represents a grant of restricted stock units that vest in twelve equal quarterly installments commencing July 15, 2022. Read SEC document
December 28, 2021 Filed Dec 30, 2021 18:05 UTC	Change Healthcare Inc. CHNG · Entity 15437	Tax withholdingCommon Stock	73,976	$21.44	$1,586,045.44	Disclosure SEC source: 0001062993-21-013691 · form4.xml · nonDerivative · entry 2 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,016,649 F2 · shares: The shares reported were withheld from the shares deliverable upon vesting of the RSUs to satisfy tax withholding requirements. Read SEC document
December 28, 2021 Filed Dec 30, 2021 18:05 UTC	Change Healthcare Inc. CHNG · Entity 15437	GrantCommon Stock	187,990	$0.00	$0.00	Disclosure SEC source: 0001062993-21-013691 · form4.xml · nonDerivative · entry 1 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,090,625 F1 · shares: In connection with the anticipated transactions contemplated by the Agreement and Plan of Merger whereby the Issuer will be acquired by UnitedHealth Group Incorporated, the Compensation Committee of the Board of Directors of the Issuer accelerated the payment of certain restricted stock unit ("RSU") awards granted on (i) August 20, 2019, (ii) June 17, 2020, and (iii) April 1, 2021 in connection with certain tax-planning actions to mitigate adverse tax consequences of Section 280G and Section 4999 of the Internal Revenue Code of 1986 (as amended). Read SEC document
December 28, 2021 Filed Feb 25, 2022 16:39 UTC Amendment	Change Healthcare Inc. CHNG · Entity 15437	Exercise / conversionCash-Settled Restricted Stock Units · Derivative	49,774	$0.00	$0.00	Disclosure SEC source: 0001062993-22-005765 · form4a.xml · derivative · entry 13 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 49,774 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each cash-settled restricted stock unit represents the contingent right to receive the cash value of one share of the Company's Common Stock upon vesting F2 · derivative.exercise_date: Pursuant to a grant on August 20, 2019, whereby (a) one-third will vest on each of August 1, 2021 and 2022; and (b) one-third will vest on August 1, 2021, unless a Qualified MCK Exit (as defined in the LLC Agreement of Change Healthcare LLC) has occurred prior to the second anniversary of the Company's initial public offering, in which case such one-third of the cash-settled restricted stock units will instead vest on the later of (x) August 20, 2020 and (y) the date that is 30 days after a Qualified MCK Exit. F2 · derivative.expiration_date: Pursuant to a grant on August 20, 2019, whereby (a) one-third will vest on each of August 1, 2021 and 2022; and (b) one-third will vest on August 1, 2021, unless a Qualified MCK Exit (as defined in the LLC Agreement of Change Healthcare LLC) has occurred prior to the second anniversary of the Company's initial public offering, in which case such one-third of the cash-settled restricted stock units will instead vest on the later of (x) August 20, 2020 and (y) the date that is 30 days after a Qualified MCK Exit. Read SEC document
December 28, 2021 Filed Feb 25, 2022 16:39 UTC Amendment	Change Healthcare Inc. CHNG · Entity 15437	Tax withholdingCommon Stock	54,389	$21.44	$1,166,100.16	Disclosure SEC source: 0001062993-22-005765 · form4a.xml · nonDerivative · entry 9 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 848,246 F1 · shares: Each cash-settled restricted stock unit represents the contingent right to receive the cash value of one share of the Company's Common Stock upon vesting F4 · balance_after: The Form 4 filed on December 30, 2021, is being amended to remove the transaction reporting the acquisition of certain underlying RSUs, as such shares had already previously been reported at the time of grant of the RSUs and to correct the number of shares withheld from the shares deliverable upon vesting of the RSUs to satisfy tax withholding requirements, as well as the amount of securities beneficially owned following the reported transaction The amount of securities beneficially owned following the reported transaction reflects the current balance as of the filing date. Read SEC document
December 28, 2021 Filed Feb 25, 2022 16:39 UTC Amendment	Change Healthcare Inc. CHNG · Entity 15437	Disposition to issuerCommon Stock	49,774	$21.44	$1,067,154.56	Disclosure SEC source: 0001062993-22-005765 · form4a.xml · nonDerivative · entry 8 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 902,635 Read SEC document
December 28, 2021 Filed Feb 25, 2022 16:39 UTC Amendment	Change Healthcare Inc. CHNG · Entity 15437	Exercise / conversionCommon Stock	49,774	Not disclosed	Not disclosed	Disclosure SEC source: 0001062993-22-005765 · form4a.xml · nonDerivative · entry 7 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 952,409 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each cash-settled restricted stock unit represents the contingent right to receive the cash value of one share of the Company's Common Stock upon vesting Read SEC document
August 01, 2021 Filed Feb 25, 2022 16:39 UTC Amendment	Change Healthcare Inc. CHNG · Entity 15437	Exercise / conversionCash-Settled Restricted Stock Units · Derivative	49,775	$0.00	$0.00	Disclosure SEC source: 0001062993-22-005765 · form4a.xml · derivative · entry 12 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,774 Underlying: Common Stock · 49,775 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each cash-settled restricted stock unit represents the contingent right to receive the cash value of one share of the Company's Common Stock upon vesting F2 · derivative.exercise_date: Pursuant to a grant on August 20, 2019, whereby (a) one-third will vest on each of August 1, 2021 and 2022; and (b) one-third will vest on August 1, 2021, unless a Qualified MCK Exit (as defined in the LLC Agreement of Change Healthcare LLC) has occurred prior to the second anniversary of the Company's initial public offering, in which case such one-third of the cash-settled restricted stock units will instead vest on the later of (x) August 20, 2020 and (y) the date that is 30 days after a Qualified MCK Exit. F2 · derivative.expiration_date: Pursuant to a grant on August 20, 2019, whereby (a) one-third will vest on each of August 1, 2021 and 2022; and (b) one-third will vest on August 1, 2021, unless a Qualified MCK Exit (as defined in the LLC Agreement of Change Healthcare LLC) has occurred prior to the second anniversary of the Company's initial public offering, in which case such one-third of the cash-settled restricted stock units will instead vest on the later of (x) August 20, 2020 and (y) the date that is 30 days after a Qualified MCK Exit. Read SEC document
August 01, 2021 Filed Feb 25, 2022 16:39 UTC Amendment	Change Healthcare Inc. CHNG · Entity 15437	Disposition to issuerCommon Stock	49,775	$21.71	$1,080,615.25	Disclosure SEC source: 0001062993-22-005765 · form4a.xml · nonDerivative · entry 6 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 902,635 Read SEC document
August 01, 2021 Filed Feb 25, 2022 16:39 UTC Amendment	Change Healthcare Inc. CHNG · Entity 15437	Exercise / conversionCommon Stock	49,775	Not disclosed	Not disclosed	Disclosure SEC source: 0001062993-22-005765 · form4a.xml · nonDerivative · entry 5 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 952,410 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each cash-settled restricted stock unit represents the contingent right to receive the cash value of one share of the Company's Common Stock upon vesting Read SEC document
June 22, 2021 Filed Jun 24, 2021 14:28 UTC	Change Healthcare Inc. CHNG · Entity 15437	Tax withholdingCommon Stock	107,249	$23.15	$2,482,814.35	Disclosure SEC source: 0001062993-21-005922 · form4.xml · nonDerivative · entry 2 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 902,635 F2 · shares: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of shares of exit-vesting restricted stock described in footnote 1. Read SEC document
June 22, 2021 Filed Jun 24, 2021 14:28 UTC	Change Healthcare Inc. CHNG · Entity 15437	GrantCommon Stock	272,550	$0.00	$0.00	Disclosure SEC source: 0001062993-21-005922 · form4.xml · nonDerivative · entry 1 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,009,884 F1 · shares: Reflects the vesting of shares of 2.5x exit-vesting restricted stock that were granted in connection with the Company's JV with McKesson as replacement awards for unvested exit-vesting Legacy CHC stock options. The shares of exit-vesting restricted stock vested upon achievement of certain performance criteria on June 22, 2021. Read SEC document
June 17, 2021 Filed Feb 25, 2022 16:39 UTC Amendment	Change Healthcare Inc. CHNG · Entity 15437	Exercise / conversionCash-Settled Restricted Stock Units · Derivative	65,847	$0.00	$0.00	Disclosure SEC source: 0001062993-22-005765 · form4a.xml · derivative · entry 11 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 65,847 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each cash-settled restricted stock unit represents the contingent right to receive the cash value of one share of the Company's Common Stock upon vesting F3 · derivative.exercise_date: Pursuant to a grant on June 17, 2020, these cash-settled restricted stock units vested in full on June 17, 2021. F3 · derivative.expiration_date: Pursuant to a grant on June 17, 2020, these cash-settled restricted stock units vested in full on June 17, 2021. Read SEC document
June 17, 2021 Filed Feb 25, 2022 16:39 UTC Amendment	Change Healthcare Inc. CHNG · Entity 15437	Disposition to issuerCommon Stock	65,847	$23.07	$1,519,090.29	Disclosure SEC source: 0001062993-22-005765 · form4a.xml · nonDerivative · entry 4 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 902,635 Read SEC document
June 17, 2021 Filed Feb 25, 2022 16:39 UTC Amendment	Change Healthcare Inc. CHNG · Entity 15437	Exercise / conversionCommon Stock	65,847	Not disclosed	Not disclosed	Disclosure SEC source: 0001062993-22-005765 · form4a.xml · nonDerivative · entry 3 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 968,482 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each cash-settled restricted stock unit represents the contingent right to receive the cash value of one share of the Company's Common Stock upon vesting Read SEC document
April 01, 2021 Filed Apr 2, 2021 17:07 UTC	Change Healthcare Inc. CHNG · Entity 15437	GrantCommon Stock	289,473	$0.00	$0.00	Disclosure SEC source: 0001062993-21-003397 · form4.xml · nonDerivative · entry 1 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 737,334 F1 · shares: Represents a grant of restricted stock units that vest as follows: 25% will vest on each of April 1, 2022, 2023, 2024, and 2025. F2 · balance_after: The number of securities reported reflects the acquisition on March 31, 2021 of 1,674 shares of Change Healthcare Inc.'s common stock pursuant to the Change Healthcare Inc. Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of October 1, 2020 through March 31, 2021. Read SEC document
August 20, 2020 Filed Feb 25, 2022 16:39 UTC Amendment	Change Healthcare Inc. CHNG · Entity 15437	Exercise / conversionCash-Settled Restricted Stock Units · Derivative	49,774	$0.00	$0.00	Disclosure SEC source: 0001062993-22-005765 · form4a.xml · derivative · entry 10 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,549 Underlying: Common Stock · 49,774 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each cash-settled restricted stock unit represents the contingent right to receive the cash value of one share of the Company's Common Stock upon vesting F2 · derivative.exercise_date: Pursuant to a grant on August 20, 2019, whereby (a) one-third will vest on each of August 1, 2021 and 2022; and (b) one-third will vest on August 1, 2021, unless a Qualified MCK Exit (as defined in the LLC Agreement of Change Healthcare LLC) has occurred prior to the second anniversary of the Company's initial public offering, in which case such one-third of the cash-settled restricted stock units will instead vest on the later of (x) August 20, 2020 and (y) the date that is 30 days after a Qualified MCK Exit. F2 · derivative.expiration_date: Pursuant to a grant on August 20, 2019, whereby (a) one-third will vest on each of August 1, 2021 and 2022; and (b) one-third will vest on August 1, 2021, unless a Qualified MCK Exit (as defined in the LLC Agreement of Change Healthcare LLC) has occurred prior to the second anniversary of the Company's initial public offering, in which case such one-third of the cash-settled restricted stock units will instead vest on the later of (x) August 20, 2020 and (y) the date that is 30 days after a Qualified MCK Exit. Read SEC document
August 20, 2020 Filed Feb 25, 2022 16:39 UTC Amendment	Change Healthcare Inc. CHNG · Entity 15437	Disposition to issuerCommon Stock	49,775	$12.93	$643,590.75	Disclosure SEC source: 0001062993-22-005765 · form4a.xml · nonDerivative · entry 2 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 902,635 Read SEC document
August 20, 2020 Filed Feb 25, 2022 16:39 UTC Amendment	Change Healthcare Inc. CHNG · Entity 15437	Exercise / conversionCommon Stock	49,775	Not disclosed	Not disclosed	Disclosure SEC source: 0001062993-22-005765 · form4a.xml · nonDerivative · entry 1 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 952,410 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Pursuant to a grant on August 20, 2019, whereby (a) one-third will vest on each of August 1, 2021 and 2022; and (b) one-third will vest on August 1, 2021, unless a Qualified MCK Exit (as defined in the LLC Agreement of Change Healthcare LLC) has occurred prior to the second anniversary of the Company's initial public offering, in which case such one-third of the cash-settled restricted stock units will instead vest on the later of (x) August 20, 2020 and (y) the date that is 30 days after a Qualified MCK Exit. F1 · price: Each cash-settled restricted stock unit represents the contingent right to receive the cash value of one share of the Company's Common Stock upon vesting Read SEC document
June 17, 2020 Filed Jun 19, 2020 16:42 UTC	Change Healthcare Inc. CHNG · Entity 15437	GrantCash-Settled Restricted Stock Units · Derivative	65,847	$0.00	$0.00	Disclosure SEC source: 0001062993-20-002933 · form4.xml · derivative · entry 2 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,171 Underlying: Common Stock · 65,847 shares Expires not disclosed F2 · derivative.exercise_price: Each cash-settled restricted stock unit represents the contingent right to receive the cash value of one share of the Company's Common Stock upon vesting. F3 · derivative.exercise_date: These cash-settled restricted stock units vest in full on June 17, 2021. F3 · derivative.expiration_date: These cash-settled restricted stock units vest in full on June 17, 2021. Read SEC document
June 17, 2020 Filed Jun 19, 2020 16:42 UTC	Change Healthcare Inc. CHNG · Entity 15437	GrantCommon Stock	197,541	$0.00	$0.00	Disclosure SEC source: 0001062993-20-002933 · form4.xml · nonDerivative · entry 1 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 446,187 F1 · shares: Represents a grant of restricted stock units, which will vest as follows: one-third will vest on each of June 17, 2022, 2023 and 2024. Read SEC document
May 01, 2020 Filed May 5, 2020 16:20 UTC	Change Healthcare Inc. CHNG · Entity 15437	GrantStock Appreciation Right · Derivative	314,595	Not disclosed Strike: $0.38	Not disclosed	Disclosure SEC source: 0001778464-20-000001 · primary_doc.xml · derivative · entry 1 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,595 Underlying: Common Stock · 314,595 shares Expires 2022-09-30 F1 · kind: On May 1, 2020, pursuant to a Merger Agreement, dated as of April 30, 2020, entered into by and among Change Healthcare Solutions, LLC, a wholly owned subsidiary of the Issuer (the "Purchaser"), Change Healthcare Solutions MergerCo Inc., a wholly owned subsidiary of the Purchaser (the "Merger Sub"), eRx Network Holdings, Inc. (the "Target"), and other parties thereto, Merger Sub merged with and into Target, with Target being the surviving entity of such merger and becoming a wholly owned subsidiary of Purchaser (the "Merger"). In connection with the Merger, pursuant to a rollover arrangement with the Issuer, certain of the Reporting Person's equity awards of Target converted into equity awards of the Issuer. F1 · price: On May 1, 2020, pursuant to a Merger Agreement, dated as of April 30, 2020, entered into by and among Change Healthcare Solutions, LLC, a wholly owned subsidiary of the Issuer (the "Purchaser"), Change Healthcare Solutions MergerCo Inc., a wholly owned subsidiary of the Purchaser (the "Merger Sub"), eRx Network Holdings, Inc. (the "Target"), and other parties thereto, Merger Sub merged with and into Target, with Target being the surviving entity of such merger and becoming a wholly owned subsidiary of Purchaser (the "Merger"). In connection with the Merger, pursuant to a rollover arrangement with the Issuer, certain of the Reporting Person's equity awards of Target converted into equity awards of the Issuer. F2 · derivative.exercise_date: These stock appreciation rights are fully vested. Read SEC document
August 20, 2019 Filed Aug 22, 2019 17:27 UTC	Change Healthcare Inc. CHNG · Entity 15437	GrantCash-Settled Restricted Stock Units · Derivative	149,324	$0.00	$0.00	Disclosure SEC source: 0000899243-19-022321 · doc4.xml · derivative · entry 2 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,324 Underlying: Common Stock · 149,324 shares Expires not disclosed F2 · derivative.exercise_price: Each cash-settled restricted stock unit represents the contingent right to receive the cash value of one share of the Company's Common Stock upon vesting. F3 · derivative.exercise_date: These cash-settled restricted stock units vest as follows: (a) one-third will vest on each of August 1, 2021 and 2022; and (b) one-third will vest on August 1, 2021, unless a Qualified MCK Exit (as defined in the LLC Agreement of Change Healthcare LLC) has occurred prior to the second anniversary of the Company's initial public offering, in which case such one-third of the cash-settled restricted stock units will instead vest on the later of (x) August 20, 2020 and (y) the date that is 30 days after a Qualified MCK Exit. F3 · derivative.expiration_date: These cash-settled restricted stock units vest as follows: (a) one-third will vest on each of August 1, 2021 and 2022; and (b) one-third will vest on August 1, 2021, unless a Qualified MCK Exit (as defined in the LLC Agreement of Change Healthcare LLC) has occurred prior to the second anniversary of the Company's initial public offering, in which case such one-third of the cash-settled restricted stock units will instead vest on the later of (x) August 20, 2020 and (y) the date that is 30 days after a Qualified MCK Exit. Read SEC document
August 20, 2019 Filed Aug 22, 2019 17:27 UTC	Change Healthcare Inc. CHNG · Entity 15437	GrantCommon Stock	49,774	$0.00	$0.00	Disclosure SEC source: 0000899243-19-022321 · doc4.xml · nonDerivative · entry 1 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,646 F1 · shares: Represents a grant of restricted stock units, which will vest in full on August 1, 2023. Read SEC document
August 15, 2019 Filed Aug 19, 2019 16:32 UTC	Change Healthcare Inc. CHNG · Entity 15437	PurchaseCommon Stock	75,000	$14.17	$1,062,750.00	Disclosure SEC source: 0000899243-19-022044 · doc4.xml · nonDerivative · entry 1 De Crescenzo Neil E. · CIK 0001778464 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,872 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $13.95 to $14.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.